• Conclusions
We have identified novel methylation biomarkers that could predict
future onset of diabetes in this high-risk population. Use of
methylation analyses to identify women who are likely to develop
diabetes at diagnosis of PCOS may facilitate timely lifestyle
interventions and reduce future morbidity.